Drawing for EPIT

USPTO serial 79116353

EPIT

Reviewed by CopyMark Law Group

Reg. 4326432Status 404
Filing date
Status date
Registration date
Apr 30, 2013
Examiner
LEE, JANET H
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EPIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Medical research in the field of immunotherapy; medical research, namely, designing a scientific method for desensitization via epicutaneous immunotherapy, without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intact; scientific research in the field of allergy treatments and therapies; scientific research relating to allergy treatments that are repeatedly applied to the skin without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intact to prevent the allergen from getting into the blood; medical research, namely, discovery and development of allergens; medical research, namely, designing treatment methods for allergies by associating allergens to immune cells present in the skin; medical research, namely, designing treatment methods for allergies consisting of the application of a patch on the intact skin of the patient without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intactSECTION 71 - CANCELLED—
044Medical services consisting of the application of a desensitization method using immunotherapy; medical treatments comprising the administration of allergens by putting a patch on the intact skin of a patient to prevent the allergen from getting into the blood; medical treatments using desensitization via epicutaneous immunotherapy; epicutaneous medical treatments without the skin being pre-prepared excluding a light cleaning that leaves the cellular structure of the epidermis intact; consulting in the field of medical care, namely, desensitizing against allergiesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 27, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 17, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 20, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 17, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 1, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 10, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 14, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 14, 2020INPCINVALIDATION PROCESSED—
Aug 6, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 6, 2019C71TCANCELLED SECTION 71—
Apr 30, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 17, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 19, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 18, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 8, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 8, 2014FIMPFINAL DISPOSITION PROCESSED—
Nov 12, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 30, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2013GPNXNOTIFICATION PROCESSED BY IB—
Feb 12, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 12, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 23, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 23, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 23, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 7, 2013ALIEASSIGNED TO LIE—
Dec 18, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 7, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 7, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 7, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 7, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2012RFNPREFUSAL PROCESSED BY IB—
Sep 13, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 13, 2012RFRRREFUSAL PROCESSED BY MPU—
Sep 8, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 7, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2012RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Sep 7, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 6, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2012DOCKASSIGNED TO EXAMINER—
Sep 4, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 31, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 30, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance